Skip to main content

Advertisement

Log in

Inter-State Variation in Human Papilloma Virus Vaccine Coverage Among Adolescent Girls in the 50 US States, 2007

  • Published:
Maternal and Child Health Journal Aims and scope Submit manuscript

Abstract

Human papilloma virus (HPV) vaccination could substantially reduce the burden of cervical cancer by preventing HPV infection. This study uses the 2007 National Survey of Children’s Health (NSCH) to estimate HPV vaccine coverage prevalence for US girls aged 12–17, the target group for vaccination. NSCH is a population-based telephone survey of households with children younger than 18 years. The proportion of girls aged 12–17 whose parent or guardian reported receipt of a clinician recommendation for HPV vaccination, one or more does of HPV vaccine, or a complete three-dose HPV vaccine series were estimated. Multivariable models estimated adjusted associations and marginal predicted vaccine coverage prevalence for each of the 50 US states and according to race/ethnicity, household income, insurance status, parental education, and whether the girl had a ‘medical home’. The NSCH sample included 17,264 girls aged 12–17. Overall 18.2 % (SE 0.8 %) of girls reportedly received at least one HPV vaccine dose and 3.6 % (SE 0.4 %) completed the series; 31 % received clinician recommendation for HPV vaccine. Girls who received a clinician recommendation to vaccinate were 23 (95 % CI 18–29) times as likely to be vaccinated as those not counseled. There was substantial interstate variation in vaccine coverage that was largely explained by variability in clinician counseling. For 2007, there was substantial variation in HPV vaccine coverage among US girls 12–17 years that was largely explained by variability in clinician counseling. Strategies aimed at increasing clinicians’ counseling for HPV vaccination could substantially reduce disparities in HPV vaccine coverage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

HPVL:

Human papilloma virus

NSCH:

National Survey of Children’s Health

NCHS:

National Center for Health Statistics

ACIP:

Advisory Committee on Immunization Practice

ACS:

American Cancer Society

AAP:

American Academy of Pediatrics

NIS-Teen:

National Immunization Survey of Teens

OR:

Odds Ratio

CI:

Confidence Interval

References

  1. Forhan, S. E., Gottlieb, S. L., Sternberg, M. R., et al. (2009). Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States. Pediatrics, 124(6), 1505–1512.

    Article  PubMed  Google Scholar 

  2. Centers for Disease Control and Prevention. (2008). HPV Vaccine Information for Clinicians. Atlanta, GA. (http://www.cdc.gov/std/hpv/STDFact-HPV-vaccine-hcp.htm). Accessed 23 Aug 2010.

  3. American Cancer Society. (2010). Cancer facts and figures 2010. Atlanta: American Cancer Society.

    Google Scholar 

  4. Saslow, D., Castle, P. E., Cox, J. T., et al. (2007). American cancer society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA: A Cancer Journal for Clinicians, 57(1), 7–28.

    Article  Google Scholar 

  5. Markowitz, L. E., Dunne, E. F., Saraiya, M., et al. (2007). Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR—Recommendations and Reports, 56(RR-2), 1–24.

    Google Scholar 

  6. National, state, and local area vaccination coverage among adolescents aged 13–17 years–United States, 2008. MMWR Morbidity and Mortality Weekly Report 2009, 58(36):997–1001.

  7. Vaccination coverage among adolescents aged 13–17 years—United States, 2007. MMWR Morbidity and Mortality Weekly Report 2008, 57(40):1100–1103.

  8. Fang, C. Y., Coups, E. J., & Heckman, C. J. (2010). Behavioral correlates of HPV vaccine acceptability in the 2007 health information national trends survey (HINTS). Cancer Epidemiology, Biomarkers and Prevention, 19(2), 319–326.

    Article  PubMed  Google Scholar 

  9. Gerend, M. A., Lee, S. C., & Shepherd, J. E. (2007). Predictors of human papillomavirus vaccination acceptability among underserved women. Sexually Transmitted Diseases, 34(7), 468–471.

    PubMed  Google Scholar 

  10. Pruitt, S. L., & Schootman, M. (2010). Geographic disparity, area poverty, and human papillomavirus vaccination. American Journal of Preventive Medicine, 38(5), 525–533.

    Article  PubMed  Google Scholar 

  11. Uddin, M., Cherkowski, G. C., Liu, G., et al. (2009). Demographic and socioeconomic determinants of influenza vaccination disparities among university students. Journal of Epidemiology and Community Health, 64(9), 808–813.

    Article  PubMed  Google Scholar 

  12. Cook, R. L., Zhang, J., Mullins, J., et al. (2010). Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid. Journal of Adolescent Health, 47(6), 596–599.

    Article  PubMed  Google Scholar 

  13. Lechuga, J., Swain, G. R., & Weinhardt, L. S. (2011). The cross-cultural variation of predictors of human papillomavirus vaccination intentions. Journal of Women’s Health (Larchmt), 20(2), 225–230.

    Article  Google Scholar 

  14. Taylor, L., Hariri, S., Sternberg, M., et al. (2011). Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007–2008. Preventive Medicine, 52(5), 398–400.

    Article  PubMed  Google Scholar 

  15. Medical home initiatives for children with special needs project advisory committee. (2002). The medical home. Pediatrics, 110(1 Pt 1), 184–186.

    Article  Google Scholar 

  16. The Child and Adolescent Health Measurement Initiative. Measuring Medical Home for Children and Youth. National Center for Health Statistics; 2009. (http://medicalhomedata.org/Viewdocument.aspx?item=521). Accessed.

  17. U.S. Department of Health and Human Services, Health Resources and Services Administration, Maternal and Child Health Bureau. The National Survey of Children with Special Health Care Needs Chartbook 2005–2006. Rockville, MD: U.S. Department of Health and Human Services, 2007.

  18. Blumberg, S. J., Foster E. B., Skalland, B. J., et al. (2009). Design and operation of the National Survey of Children’s Health, 2007. Vital Health Statistics 1: National Center for Health Statistics.

  19. Pedlow, S., Luke, J. V., Blumberg, S. J. (2007). Multiple imputation of missing household poverty level values from the National Survey of Children with Special Health Care Needs, 2001, and the National Survey of Children’s Health, 2003. (http://www.cdc.gov/nchs/data/slaits/mimp01_03.pdf). Accessed 5 Jan 2011.

  20. Colgrove, J., Abiola, S., & Mello, M. M. (2010). HPV vaccination mandates—lawmaking amid political and scientific controversy. New England Journal of Medicine, 363(8), 785–791.

    Article  PubMed  CAS  Google Scholar 

  21. National Center of State Legislatures. (2011). HPV Vaccine: State Legislation and Statutes. (http://www.ncsl.org/default.aspx?tabid=14381). Accessed 1 Feb 2011.

  22. Gollust, S. E., Dempsey, A. F., Lantz, P. M., et al. (2010). Controversy undermines support for state mandates on the human papillomavirus vaccine. Health Affairs (Millwood), 29(11), 2041–2046.

    Article  Google Scholar 

  23. Ko, E. M., Missmer, S., & Johnson, N. R. (2010). Physician attitudes and practice toward human papillomavirus vaccination. Journal of Lower Genital Tract Disease, 14(4), 339–345.

    Article  PubMed  Google Scholar 

  24. Kahn, J. A., Zimet, G. D., Bernstein, D. I., et al. (2005). Pediatricians’ intention to administer human papillomavirus vaccine: The role of practice characteristics, knowledge, and attitudes. Journal of Adolescent Health, 37(6), 502–510.

    Article  PubMed  Google Scholar 

  25. American Cancer Society. (2010). How much does the HPV vaccine cost? Is it covered by health insurance plans? (http://www.cancer.org/Cancer/CancerCauses/OtherCarcinogens/InfectiousAgents/HPV/HumanPapillomaVirusandHPVVaccinesFAQ/hpv-faq-vaccine-cost). Accessed 18 April 2011.

  26. Guerry, S. L., De Rosa, C. J., Markowitz, L. E., et al. (2011). Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine, 29(12), 2235–2241.

    Article  PubMed  Google Scholar 

  27. Staras, S. A., Vadaparampil, S. T., Haderxhanaj, L. T., et al. (2010). Disparities in human papillomavirus vaccine series initiation among adolescent girls enrolled in Florida Medicaid programs, 2006–2008. Journal of Adolescent Health, 47(4), 381–388.

    Article  PubMed  Google Scholar 

  28. Dorell, C. G., Jain, N., & Yankey, D. (2008). Validity of parent-reported vaccination status for adolescents aged 13–17 years, National Immunization Survey-Teen. Public Health Reports (in press).

  29. Jain, N., Singleton, J. A., Montgomery, M., et al. (2009). Determining accurate vaccination coverage rates for adolescents: The national immunization survey-teen 2006. Public Health Reports, 124(5), 642–651.

    PubMed  Google Scholar 

  30. Molinari, N. M., Wolter, K. M., Skalland, B., et al. (2011). Quantifying bias in a health survey: Modeling total survey error in the National Immunization Survey. Stat Med, 30(5), 505–514.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael R. Kramer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kramer, M.R., Dunlop, A.L. Inter-State Variation in Human Papilloma Virus Vaccine Coverage Among Adolescent Girls in the 50 US States, 2007. Matern Child Health J 16 (Suppl 1), 102–110 (2012). https://doi.org/10.1007/s10995-012-0999-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10995-012-0999-6

Keywords

Navigation